← Back to all trials
Recruiting
NCT03150511
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
Conditions: Peripheral Nerve Injuries
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 36
Sponsor: Johns Hopkins University
Location: Sami Tuffaha Baltimore Maryland
Summary
The aim of this clinical trial is to evaluate the efficacy of tesamorelin as a therapy for peripheral nerve injuries. The investigators hypothesize that treatment with tesamorelin will result in faster and more substantial recovery of motor and sensory function following surgical repair of injured peripheral nerves. Patients with upper extremity nerve injuries will be randomly assigned to receive either tesamorelin treatment or no treatment. Assessments for nerve regeneration, muscle function, and sensation will be conducted every three months for a total of 12 months. Outcomes in patients receiving tesamorelin will be compared to those in the untreated group to determine the effectiveness of tesamorelin as a therapeutic intervention for nerve injuries.
Eligibility Criteria
Inclusion Criteria:
* Ulnar nerve laceration at the wrist, repaired primarily
Exclusion Criteria:
* Certain cancers (active or in the past)
* Uncontrolled diabetes or hypertension
* Certain pituitary problems
* Oral contraceptives
* Pregnancy
* Drug or alcohol dependence
* Psychosocial issues that would limit participation and compliance
Source: ClinicalTrials.gov (NCT03150511). StuddyBuddy aggregates publicly available trial information.